Trials & Tribulations Canine cancers as models: We have barely tapped the full potential of comparative oncology May 03, 2024Vol.50 No.18By Christina K. Lopes
Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials April 12, 2024Vol.50 No.15By Jacquelyn Cobb
Trials & Tribulations A new standard in cancer care: Integrated screening, stepped collaborative care for common and distressing symptoms April 05, 2024Vol.50 No.14By Jennifer A. Steel
Multi-target FIT aims to offer inexpensive, high-sensitivity alternative to FIT in colorectal cancer screening March 01, 2024Vol.50 No.09By Matthew Bin Han Ong
Trials & Tribulations Cancer AI systems: We need oncologists to help us build trusted models March 01, 2024Vol.50 No.09By Bernard Chien
First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval February 23, 2024Vol.50 No.08By Matthew Bin Han Ong
Trials & Tribulations Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry February 09, 2024Vol.50 No.06By Narjust Florez, Lauren Keil, Rebekah Kaufman and Oyepeju Abioye-Akintola
FDA, Friends identify next steps for dose optimization, pragmatic trials, academic-led studies for drug approvals December 15, 2023Vol.49 No.46By Matthew Bin Han Ong
ESMO discussants urge physicians to prescribe lower dose of Amgen’s sotorasib November 17, 2023Vol.49 No.43By Paul Goldberg
After revolutionizing treatment of blood cancers, imatinib stands poised to eradicate malaria November 03, 2023Vol.49 No.41By Jacquelyn Cobb
